Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lee Mosley

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Biomaterials|October 24, 2017
Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profilesTian Zhou, Hang Su, Prasanta Dash, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 8, 2017
Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell FunctionFany M Iseka, Benjamin T Goetz, Insha Mushtaq, et al.
Theranostics|January 7, 2020
Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissuesBhavesh D Kevadiya, Brendan Ottemann, Insiya Z Mukadam, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 12, 2012
CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's diseaseJessica A Hutter Saunders, Katherine A Estes, Lisa M Kosloski, et al.
Theranostics|February 16, 2026
Colostrum extracellular vesicles are neuroprotective in models of Parkinson's diseaseDawson Hollingsworth, Shefali Srivastava, Samia Akter, et al.
Journal of Neuroinflammation|November 20, 2021
CD4+ effector T cells accelerate Alzheimer's disease in miceJatin Machhi, Pravin Yeapuri, Yaman Lu, et al.
NPJ Parkinson'S Disease|June 27, 2017
Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trialHoward E Gendelman, Yuning Zhang, Pamela Santamaria, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2023
CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized micePrasanta K Dash, Chen Chen, Rafal Kaminski, et al.
Nature Materials|April 29, 2020
A year-long extended release nanoformulated cabotegravir prodrugTanmay A Kulkarni, Aditya N Bade, Brady Sillman, et al.
Nature Communications|July 4, 2019
Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized MicePrasanta K Dash, Rafal Kaminski, Ramona Bella, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Biomaterials|October 24, 2017
Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profilesTian Zhou, Hang Su, Prasanta Dash, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 8, 2017
Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell FunctionFany M Iseka, Benjamin T Goetz, Insha Mushtaq, et al.
Theranostics|January 7, 2020
Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissuesBhavesh D Kevadiya, Brendan Ottemann, Insiya Z Mukadam, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 12, 2012
CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's diseaseJessica A Hutter Saunders, Katherine A Estes, Lisa M Kosloski, et al.
Theranostics|February 16, 2026
Colostrum extracellular vesicles are neuroprotective in models of Parkinson's diseaseDawson Hollingsworth, Shefali Srivastava, Samia Akter, et al.
Journal of Neuroinflammation|November 20, 2021
CD4+ effector T cells accelerate Alzheimer's disease in miceJatin Machhi, Pravin Yeapuri, Yaman Lu, et al.
NPJ Parkinson'S Disease|June 27, 2017
Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trialHoward E Gendelman, Yuning Zhang, Pamela Santamaria, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2023
CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized micePrasanta K Dash, Chen Chen, Rafal Kaminski, et al.
Nature Materials|April 29, 2020
A year-long extended release nanoformulated cabotegravir prodrugTanmay A Kulkarni, Aditya N Bade, Brady Sillman, et al.
Nature Communications|July 4, 2019
Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized MicePrasanta K Dash, Rafal Kaminski, Ramona Bella, et al.
Pageof 11